Bioperfectus Launching HPV Series Real Time PCR Kit to the Global Market

Company news



Cervical canceris a life-threating disease in the women’s cervix, which is the fourth killer among cancers for females.


The infection of high-riskHPVhas a strong association with incidence of cervical cancer.There are more than 100 types of HPV. Each type has specific preferred infected area. These HPV can be classified into two groups according to the potential risks to develop cancer, high-risk HPV (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59, 66 and 68) and low-risk HPV (6, 11, 81).


With the dedication to building a healthier life for human being, today weBioperfectusare glad to launch our HPV series Real Time PCR Kits (Human Papillomavirus Real Time PCR Kit& Human Papillomavirus Genotyping Real Time PCR Kit) to the global market.


Bioperfectus Human Papillomavirus Real Time PCR Kitis a qualitative PCR assay intended to detect 18 high-risk genotypes of the human papillomavirus (HPV), including HPV-16, HPV-18 and other 16 common oncogenic types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, 73, 53, 82 and 26). It has high specificity and sensitivity, can be used for primary cervical cancer screening. Specific genotypes identified can assist doctors to further decide triage and treatment and  reduce morbidity and prevalence of cervical cancer. 


Screening high-risk HPV can avoid unnecessary colposcopy procedures and improve the clinical management. When certain type of HPV is identified more than once during 6 months, the patient can be considered as constant infection and further triage should be taken. It enables women to access to diagnosis at the early stage of HPV infection and to get treatment before development of precancerous lesions and cervical cancer.  Bioperfectus Human Papillomavirus Genotyping Real Time PCR Kit accurately detecting and reporting 21 types of HPV (16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 26, 73, 82, 6, 11, 81).


There is power in early diagnosis and prevention.


Inquiry regarding the product, please send email &


Value of a Catch-up HPV Test in Women Aged 65 and Above: A Danish Population-Based Nonrandomized Intervention Study

In July 2023, Mette Tranberg and others published a study titled "Value of a catch-up HPV test in women aged 65 and above: A Danish population-based nonrandomized intervention study" in the "PLOS Medicine" journal with an impact factor of 15.8.


What You Should Know About the Four Common Sexually Transmitted Diseases

Sexually transmitted diseases (STDs) are quite prevalent, and many individuals infected with STDs may not display any noticeable symptoms.


Dengue Will “Take Off” in Southern Europe, US, Africa This Decade, WHO Scientist Says

Dengue fever will become a major threat in the southern United States, southern Europe, and new parts of Africa this decade, the WHO's chief scientist said, as warmer temperatures create the conditions for the mosquitoes carrying the infection to spread.